Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...

The Department of Justice (DoJ) claims that Biohaven – before being acquired by Pfizer – paid "improper remuneration" to some Nurtec ODT (rimegepant) prescribers in the form of speaker fees ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Buy low, sell high. That has been a good strategy for investors for a long time. However, finding great stocks to buy under this approach might seem difficult right now, considering that the S&P ...

However, Pfizer believes it will be able to deliver solid growth in the second half of this decade. How? The company's product lineup features rising stars such as migraine therapy Nurtec ODT and ...